#USA #New York #Baxter International #Novum LVP #Baxter lawsuit

Introduction

Baxter International, Inc. (NYSE: BAX) is currently facing a class action lawsuit that has raised significant concerns among its investors. The suit is focused on allegations that the company's recently launched product, Novum LVP, contains systemic defects, leading to severe malfunctions that could jeopardize patient safety. The Gross Law Firm, which is managing the case, has alerted shareholders to the importance of registering before the lead plaintiff deadline of December 15, 2025.

The Allegations

According to the complaint, Baxter's Novum LVP products have been linked to a range of alarming malfunctions. These include issues such as under-infusion, over-infusion, and even complete non-delivery of fluids. Such defects are particularly concerning because they pose serious risks to patients, including the potential for significant injury or even death. Reportedly, Baxter had prior knowledge of these device malfunctions but failed to take adequate measures to rectify the situation.

The lawsuit further alleges that Baxter’s attempts to notify customers about these malfunctions through customer alerts were insufficient. Despite these communications, it appears that the design flaws remained unresolved, continuing to endanger patients. As a result of these failures, there has been a heightened risk of customers being instructed to withdraw existing Novum LVP units from use, alongside a complete halt in new sales of these devices.

Importance for Shareholders

Investors who purchased Baxter shares during the designated class period, which spans from February 23, 2022, to July 30, 2025, are particularly encouraged to contact The Gross Law Firm regarding their rights in this matter. Registering as a shareholder can also enroll individuals in a monitoring system that provides status updates throughout the duration of the lawsuit. The lead plaintiff deadline is an essential date for those looking to possibly seek lead plaintiff status in the action, as it provides a chance for shareholders to advocate for their interests in court.

Next Steps for Shareholders

For shareholders with vested interests in Baxter, it’s critical not to delay in registering your information concerning the class action case. Participation is without cost or obligation, making it a risk-free opportunity to ensure your rights as an investor are upheld. Registering early ensures you will be kept informed about developments and can participate fully in the case as it unfolds.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its advocacy in class action lawsuits, with a commitment to protecting investors against fraudulent practices. Their aim is to hold companies accountable for misleading statements and to recover losses for shareholders affected by such actions. With their experience and dedication, they seek to ensure that Baxter International and similar companies maintain good corporate citizenship standards.

Conclusion

As this class action lawsuit unfolds, it serves as a crucial reminder for investors to remain vigilant regarding the companies they are involved with. The allegations against Baxter International, particularly surrounding the Novum LVP products, are serious and merit attention. Shareholders must take timely action before the approaching deadline to safeguard their interests and pursue potential remedies for any losses incurred during the class period.

For inquiries or to register, shareholders can contact The Gross Law Firm at their New York office, ensuring they are part of this important legal action.

Contact Information for The Gross Law Firm:
15 West 38th Street, 12th floor, New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903